BioSpace News Archive

The position is a new one, as CANbridge ramps up its leadership in anticipation of upcoming regulatory filings expected for several of its programs

The company expects revenue growth to increase through 2019 as a result.

The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been eradicated.

Dr. Reddy’s Laboratories Ltd. will announce results for the Third Quarter ended December 31, 2017 on Thursday, January 25, 2018 after the Board Meeting.

Context made a one-time payment to Arno Therapeutics in exchange for the worldwide rights to Apristor.

Marken announced today the opening of a new Kit Building Center in Shanghai, the company’s third location in addition to Hamburg and Singapore.

Replicel Life Sciences is pleased to announce it has signed a Binding Term Sheet with YOFOTO to form a strategic partnership in Greater China.

Aerie announced the appointments of Nils Hauptmann as Director of Regulatory Affairs and Pharmacovigilance, reporting to Cindy Martin, Aerie’s Vice President of Regulatory, and Tim Swan as Director of Sales and Transparency Operations, reporting to Gerry McKenzie, Aerie’s Vice President of Commercial Operations.

Cellect announced that it has signed an agreement with the Hadassah Medical Center to conduct clinical trials on cancer patients in Cellect’s ongoing Phase I/II study.

Ophthotech announced today the election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, to its Board of Directors, effective immediately.